The results will be the deciding factor not personal agenda. If the primary endpoint results show a good enough benefit than CYDY gets EUA if Any of the also very important secondary end points show good benefit we will get EUA. Having EIND’s right now with a finished phase 3 trial with primary endpoint mortality 28 days along with approved OLE results would need to be clearly bad for CYDY to not get an EUA IMO.